Astrea Bioseparations prospectus

Biotage publishes prospectus for admission to trading of shares, to be issued as part of the acquisition of Astrea Bioseparations.

Financial Reports

Recent and historical reports

Take part of recent and historical financial reports such as annual reports, presentations and webcasts.

Reports

Presentations

The Share

Press Releases & News

Calendar

Corporate Governance

Silent Period - Biotage applies a silent period of 30 days before quarterly reports.

Sustainability

At Biotage Sustainability is in the forefront of our work. We support our customers involved in water, food and soil testing through simplified environmental analysis and green chemistry solutions.

About Biotage

Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).

Ask a specialist

Investor Relations Home

Kort om Biotage

Biotage är ett Globalt Go-To Separations-företag, som stödjer kunder inom forskning och tillverkning av läkemedel, diagnostik och analytiska tester, med intelligenta och hållbara arbetsflödeslösningar. Vår expertis och våra högkvalitativa separationslösningar spelar en nyckelroll för att effektivisera kunders arbetsflöden och förbättra deras resultat. Biotage har sitt huvudkontor i Sverige, 700 medarbetare globalt, och levererar lösningar till över 80 länder. Vårt företag är noterat på NASDAQ Stockholm (BIOT).

Contact me about